Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mylan Nv Ord Shs (MYL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 21,218,262
  • Shares Outstanding, K 535,950
  • Annual Sales, $ 11,077 M
  • Annual Income, $ 480,000 K
  • 36-Month Beta 1.13
  • Price/Sales 1.87
  • Price/Cash Flow 5.08
  • Price/Book 1.78

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.57 +8.26%
on 04/25/17
40.10 -1.27%
on 05/23/17
+2.76 (+7.49%)
since 04/21/17
3-Month
36.54 +8.35%
on 04/21/17
45.87 -13.69%
on 03/01/17
-2.74 (-6.47%)
since 02/23/17
52-Week
33.60 +17.83%
on 11/03/16
50.40 -21.45%
on 08/09/16
-1.62 (-3.93%)
since 05/23/16

Most Recent Stories

More News
10 highest-paid female CEOs

These are the 10 highest-paid women CEOs for 2016, as calculated by The Associated Press and Equilar, an executive data firm.

MYL : 39.59 (+2.46%)
LMT : 278.36 (+0.48%)
DUK : 84.30 (+0.24%)
GD : 199.32 (+0.79%)
SmarTrend Watching for Potential Pullback in Shares of Mylan After 3.03% Gain

Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $38.79 to a high of $39.88. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $38.80 on...

MYL : 39.59 (+2.46%)
Watch for Mylan to Potentially Pullback After Gaining 3.03% Yesterday

Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $38.79 to a high of $39.88. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $38.80 on...

MYL : 39.59 (+2.46%)
Next Resistance Level for Mylan (MYL) is $38.66

Mylan (NASDAQ:MYL) has opened bullishly above the pivot of $38.11 today and has reached the first level of resistance at $38.30. Investors may be interested in a cross of the next upside pivot targets...

MYL : 39.59 (+2.46%)
Mylan (MYL) Crosses Pivot Point Support at $38.43

Shares of Mylan (NASDAQ:MYL) opened today below their pivot of $38.82 and have already reached the first level of support at $38.43. Analysts will be watching for a cross of the next downside pivot targets...

MYL : 39.59 (+2.46%)
Mylan to Present at UBS Global Healthcare Conference

Mylan N.V. (NASDAQ, TASE: MYL) today announced that the company will present at the UBS Global Healthcare Conference on Monday, May 22, 2017, in New York City. The presentation is scheduled to begin at...

MYL : 39.59 (+2.46%)
Mylan Honors National Women's Health Week to Empower Women to Take Control of Their Health

Mylan N.V. (NASDAQ, TASE: MYL) today joins the U.S. Department of Health and Human Services (HHS) Office on Women's Health in recognizing the 18th annual National Women's Health Week. This year's goal...

MYL : 39.59 (+2.46%)
Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study

While companies like Mylan (MYL), Allergan and Teva reported Q1 results this week, several companies provided updates on their cancer drugs.

MYL : 39.59 (+2.46%)
AZN : 34.08 (+0.38%)
JNJ : 127.52 (+0.20%)
MRK : 64.55 (+0.80%)
TEVA : 28.76 (-2.31%)
RHHBY : 34.3000 (-0.38%)
PFE : 32.14 (+0.06%)
Teva (TEVA) Q1 Earnings In Line, Sales Lag as Copaxone Falls

Teva Pharmaceutical Industries Ltd. (TEVA) reported first-quarter 2017 earnings of $1.03 per share (including equity compensation expenses), which was in line with the Zacks Consensus Estimate.

MYL : 39.59 (+2.46%)
AGN : 220.66 (+0.52%)
NVS : 81.06 (-0.28%)
TEVA : 28.76 (-2.31%)
Company News for May 11, 2017

Companies in the News are: MYL,YELP,EA,WEN

MYL : 39.59 (+2.46%)
WEN : 16.17 (+0.56%)
YELP : 27.78 (-1.80%)
EA : 109.01 (+0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More

Business Summary

Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as...

See More

Support & Resistance

2nd Resistance Point 40.80
1st Resistance Point 40.20
Last Price 39.59
1st Support Level 38.89
2nd Support Level 38.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.